JALRA M (Metformin (850mg) + Vildagliptin (50mg))

Jalra-M 50mg/850mg Tablet is formulated to assist in managing elevated blood glucose levels in individuals diagnosed with type 2 diabetes mellitus. By doing so, it plays a significant role in preventing severe complications associated with diabetes, including potential kidney impairment and vision loss. Additionally, it may lower the risk of experiencing cardiovascular events such as heart attacks and strokes. This medication can be administered as a standalone treatment or in conjunction with other antidiabetic agents. The effectiveness of all diabetes treatments is maximized when paired with a balanced diet and consistent physical activity. The prescribed dosage will vary based on individual factors such as the severity of the condition, current blood sugar readings, and any additional medications being utilized. To minimize gastrointestinal discomfort, it is advisable to take the tablet with meals. For optimal results, it is crucial to take the medication at the same time daily and to avoid discontinuing use without medical advice. Adhering to a prescribed diet and exercise routine is vital as they significantly impact diabetes management. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.